Sequential trial with B method of Potvin [Two-Stage / GS Designs]

posted by john john – Spain, 2015-10-01 19:44 (3922 d 20:46 ago) – Posting: # 15513
Views: 16,300

In a sequential clinical trial conducted like a B method of Potvin, we have Cmax and AUC both not bioequivalent. Cmax has a power <80% (71.5%), and AUC>80% (84.6%).
AUC 0-30min calculated by protocol is bioequivalent.
In the protocol it was not specified how to proceed in this situation.

Can we calculate a new n and pass to the second phase? Or we must stop the trial?

Thanks


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
361 visitors (0 registered, 361 guests [including 19 identified bots]).
Forum time: 16:31 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5